Shelter Pharma Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 28/05/2026 ,inter alia, to consider and approve Intimation of Board Meeting ....
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Shelter Pharma Ltd has informed BSE about a scheduled Board of Directors meeting on May 28, 2026. The meeting will consider and approve the Audited Financial Results for the half year and full year ended March 31, 2026, as required under SEBI regulations. This is a standard compliance filing under Regulation 29 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The filing was made on May 22, 2026, giving approximately one week's notice to the exchange. No specific agenda items or financial details are disclosed in this intimation.
This is a routine board meeting notice announcing when FY 2026 annual results will be approved. Shareholders should expect the audited financial results to be released shortly after the board meeting. No immediate impact on the stock, but the upcoming results announcement could trigger volatility depending on whether the numbers meet market expectations.